These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 24750505)
1. The development and assessment of biological treatments for children. Smith EM; Foster HE; Beresford MW Br J Clin Pharmacol; 2015 Mar; 79(3):379-94. PubMed ID: 24750505 [TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
8. Biologics in children's autoimmune disorders: efficacy and safety. Breda L; Del Torto M; De Sanctis S; Chiarelli F Eur J Pediatr; 2011 Feb; 170(2):157-67. PubMed ID: 20556424 [TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness and safety of non-tumour necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumour necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials. Sung YK; Lee YH J Clin Pharm Ther; 2021 Aug; 46(4):984-992. PubMed ID: 33600008 [TBL] [Abstract][Full Text] [Related]
10. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India. Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281 [TBL] [Abstract][Full Text] [Related]
11. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Dixon WG; Carmona L; Finckh A; Hetland ML; Kvien TK; Landewe R; Listing J; Nicola PJ; Tarp U; Zink A; Askling J Ann Rheum Dis; 2010 Sep; 69(9):1596-602. PubMed ID: 20525843 [TBL] [Abstract][Full Text] [Related]
12. Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World Use. Stach CM; Sloan VS; Woodworth TG; Kilgallen B; Furst DE Drug Saf; 2019 Dec; 42(12):1499-1506. PubMed ID: 31696432 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with withdrawal of the anti-TNFα biologics in the treatment of rheumatic diseases: data from the Hong Kong Biologics Registry. Mok CC; Chan KY; Lee KL; Tam LS; Lee KW; Int J Rheum Dis; 2014 Dec; 17 Suppl 3():1-8. PubMed ID: 24382315 [TBL] [Abstract][Full Text] [Related]
14. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491 [TBL] [Abstract][Full Text] [Related]
15. The Corrona US registry of rheumatic and autoimmune diseases. Kremer JM Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S96-S99. PubMed ID: 27762197 [TBL] [Abstract][Full Text] [Related]
16. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Herrinton LJ; Curtis JR; Chen L; Liu L; Delzell E; Lewis JD; Solomon DH; Griffin MR; Ouellet-Hellstom R; Beukelman T; Grijalva CG; Haynes K; Kuriya B; Lii J; Mitchel E; Patkar N; Rassen J; Winthrop KL; Nourjah P; Saag KG Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1199-209. PubMed ID: 21919113 [TBL] [Abstract][Full Text] [Related]
17. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462 [TBL] [Abstract][Full Text] [Related]
18. Systemic treatments for eczema: a network meta-analysis. Sawangjit R; Dilokthornsakul P; Lloyd-Lavery A; Lai NM; Dellavalle R; Chaiyakunapruk N Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013206. PubMed ID: 32927498 [TBL] [Abstract][Full Text] [Related]
19. Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward. Bagri NK; Kumar S; Ramanan AV Indian Pediatr; 2022 Dec; 59(12):913-915. PubMed ID: 36089846 [TBL] [Abstract][Full Text] [Related]